Nice price action today, anticipating uplisting, I imagine
Watched the latest presentation last night. Nothing out-of-this-world. She seemed quite confident about positive data from Ph2b trial in April.
The one negative I didn't like was that Ph2a results have not been published. Only 9 patients. Little sign of cognitive improvement. Anyone like to come on this?
Market Data 
Markets 
AI
